Revitope Oncology Obtains $8,500,000 New Financing

  • Feed Type
  • Date
    2/9/2016
  • Company Name
    Revitope Oncology
  • Mailing Address
    Undisclosed San Francisco, CA 94105 USA
  • Company Description
    Revitope Oncology, Inc. is a privately-held cancer immunotherapy company developing a novel platform based on redirecting viral immunity for the purpose of developing compounds to treat solid tumors and hematologic malignancies.
  • Website
    http://www.revitope.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds will be used to continue development of its novel immunotherapy platform for the treatment of solid tumors and hematologic malignancies.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy